Clinical Trials Browser

Recruiting × Prostatic Neoplasms × Vorinostat × Clear all

NCT06145633 2026-01-28

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms